ZeClinics is a Biotech Contract Research Organization (CRO) and early-phase biopharmaceutical (PHARMA) company using zebrafish (Danio rerio) for safety and efficacy screenings of novel chemical molecules. Our business strengths rely on high technical expertise and top-notch research facilities, combined with attractive strategic partnerships and academic collaborations.

We aim to challenge the traditional drug discovery pipeline by offering a cheap, fast, and reliable array of customized assays, to assess the safety and biomedical relevance of novel molecules using zebrafish. In a challenging economic environment, ZeClinics represents an excellent example of a business model that uses research and innovation as a way to success.